Raez LE - Search Results

1

The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.

Nagasaka M, Singh V, Baca Y, Sukari A, Kim C, Mamdani H, Spira AI, Uprety D, Bepler G, Kim ES, Raez LE, Pai SG, Ikpeazu C, Oberley M, Feldman R, Xiu J, Korn WM, Wozniak AJ, Borghaei H, Liu SV. Nagasaka M, et al. Among authors: raez le. Clin Lung Cancer. 2022 Jan;23(1):52-59. doi: 10.1016/j.cllc.2021.08.012. Epub 2021 Oct 18. Clin Lung Cancer. 2022. PMID: 34801409 Free article.

2

Induction of CD8 T-cell-Ifn-gamma response and positive clinical outcome after immunization with gene-modified allogeneic tumor cells in advanced non-small-cell lung carcinoma.

Raez LE, Cassileth PA, Schlesselman JJ, Padmanabhan S, Fisher EZ, Baldie PA, Sridhar K, Podack ER. Raez LE, et al. Cancer Gene Ther. 2003 Nov;10(11):850-8. doi: 10.1038/sj.cgt.7700641. Cancer Gene Ther. 2003. PMID: 14605671 Clinical Trial.

3

Allogeneic vaccination with a B7.1 HLA-A gene-modified adenocarcinoma cell line in patients with advanced non-small-cell lung cancer.

Raez LE, Cassileth PA, Schlesselman JJ, Sridhar K, Padmanabhan S, Fisher EZ, Baldie PA, Podack ER. Raez LE, et al. J Clin Oncol. 2004 Jul 15;22(14):2800-7. doi: 10.1200/JCO.2004.10.197. J Clin Oncol. 2004. PMID: 15254047 Clinical Trial.

4

Chemotherapy for advanced non-small-cell lung cancer.

Raez LE, Lilenbaum R. Raez LE, et al. Clin Adv Hematol Oncol. 2004 Mar;2(3):173-8. Clin Adv Hematol Oncol. 2004. PMID: 16166948 Review.

5

Lung cancer immunotherapy.

Raez LE, Fein S, Podack ER. Raez LE, et al. Clin Med Res. 2005 Nov;3(4):221-8. doi: 10.3121/cmr.3.4.221. Clin Med Res. 2005. PMID: 16303887 Free PMC article. Review.

6

Efficacy and safety of oxaliplatin and docetaxel in patients with locally advanced and metastatic non-small-cell lung cancer (NSCLC).

Raez LE, Santos ES, Lopes G, Rosado MF, Negret LM, Rocha-Lima C, Tolba K, Farfan N, Hamilton-Nelson K, Silva O, Roman E. Raez LE, et al. Lung Cancer. 2006 Sep;53(3):347-53. doi: 10.1016/j.lungcan.2006.05.023. Epub 2006 Jul 17. Lung Cancer. 2006. PMID: 16844257 Clinical Trial.

7

Efficacy and safety of oxaliplatin and gemcitabine with bevacizumab in advanced non-small cell lung cancer.

Lilenbaum R, Raez L, Tseng J, Seigel L, Davila E. Lilenbaum R, et al. J Thorac Oncol. 2008 May;3(5):511-5. doi: 10.1097/JTO.0b013e31816de28f. J Thorac Oncol. 2008. PMID: 18449004 Free article. Clinical Trial.

8

Controversies in the management of stage IIIA non-small-cell lung cancer.

Santos ES, Castrellon A, Blaya M, Raez LE. Santos ES, et al. Among authors: raez le. Expert Rev Anticancer Ther. 2008 Dec;8(12):1913-29. doi: 10.1586/14737140.8.12.1913. Expert Rev Anticancer Ther. 2008. PMID: 19046112 Review.

9

Second-line therapy for non-small-cell lung cancer.

Arango BA, Castrellon AB, Santos ES, Raez LE. Arango BA, et al. Among authors: raez le. Clin Lung Cancer. 2009 Mar;10(2):91-8. doi: 10.3816/CLC.2009.n.011. Clin Lung Cancer. 2009. PMID: 19362951 Review.

10

Gene expression profiling and non-small-cell lung cancer: where are we now?

Santos ES, Blaya M, Raez LE. Santos ES, et al. Among authors: raez le. Clin Lung Cancer. 2009 May;10(3):168-73. doi: 10.3816/CLC.2009.n.023. Clin Lung Cancer. 2009. PMID: 19443336 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page